Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Rev Proteomics. 2010 Feb;7(1):21-7. doi: 10.1586/epr.09.87.

Cancer proteome-expression database: Genome Medicine Database of Japan Proteomics.

Author information

  • 1Proteome Bioinformatics Project, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. takondo@ncc.go.jp

Abstract

The use of proteome-expression databases may facilitate cancer research. Proteome-expression data derived from a sufficient number of clinical cases may help establish the molecular background of malignant tumors. Recently, we published a proteome expression database, the Genome Medicine Database of Japan (GeMDBJ) Proteomics. The GeMDBJ Proteomics includes the proteome data of surgically resected tissues and tissue-cultured cells of various malignancies, as well as the corresponding biological and clinicopathological data. The proteome data in GeMDBJ Proteomics include expression data produced using 2D PAGE with the immobilized pH gradient gel and DIGE technology, and the protein identification data by liquid chromatography tandem mass spectrometry. GeMDBJ Proteomics can be freely accessed online without registration.

PMID:
20121473
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk